Clinical Trials Search | Clareo Health

About Pricing FAQs Blog

Loading clinical trials...

Clareo Health

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 1-2 of 2 trials

RECRUITINGPhase 3

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

NCT07262476

This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.

Thyroid Eye Disease (TED)

Minghui Pharmaceutical (Hangzhou) Ltd258 participantsStarted Jan 2026

Shanghai, Shanghai Municipality, China

Not Yet RecruitingPhase 1/2

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

NCT07404111

The goal of this study is to evaluate the safety, tolerability, and efficacy of KRIYA-586 (VV-14305) in treating thyroid eye disease (TED).

Thyroid Eye Disease (TED)

Kriya Therapeutics, Inc.110 participantsStarted Feb 2026

Auckland, New Zealand, New Zealand

Data from ClinicalTrials.govTerms

Showing 1-2 of 2 trials

RECRUITINGPhase 3

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

NCT07262476

This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.

Thyroid Eye Disease (TED)

Minghui Pharmaceutical (Hangzhou) Ltd258 participantsStarted Jan 2026

Shanghai, Shanghai Municipality, China

Not Yet RecruitingPhase 1/2

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

NCT07404111

The goal of this study is to evaluate the safety, tolerability, and efficacy of KRIYA-586 (VV-14305) in treating thyroid eye disease (TED).

Thyroid Eye Disease (TED)

Kriya Therapeutics, Inc.110 participantsStarted Feb 2026

Auckland, New Zealand, New Zealand

Data from ClinicalTrials.govTerms